Total funding for NCER-endorsed protocols stands at $22,369,079.50 as of January 2024.
TITLE | FIRST NAME | LAST NAME | ENDORSED | FUNDING |
---|---|---|---|---|
Risk Prediction Tools for Emergency Department Patients with Suspected Heart Disease | Andrew | McRae | 2018 | $123,600.00 |
The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments | Simon | Berthelot | 2018 | $100,000.00 |
Development of novel coronary artery disease risk scores in the high-sensitivity troponin era | Andrew | McRae | 2019 | |
Derivation and Internal Validation of a Clinical Prognostic Tool for Recurrent ED Visits for Hyperglycemia in Patients with Diabetes: A Multicentre Prospective Cohort Study | Justin | Yan | 2019 | $149,500.00 $25,000.00 $4,975.45 $14,990.00 |
Derivation of a clinical decision rule for emergency department head CT scanning in seniors who have fallen | Kerstin | de Wit | 2019 | $857,000.00 |
Evaluating a selective CT head scanning approach in anticoagulated head-injured emergency department patients | Kerstin | de Wit | 2019 | $1,239,300.00 |
Refinement and validation of a clinical decision rule integrating the use of biomarkers for early detection of persistent symptoms after a MTBI | Natalie | Le Sage | 2020 | $760,676.00 |
The Neighbours Saving Neighbours Feasibility Study: An intervention to increase survival from out-of-hospital cardiac arrest using a community volunteer responder model | Steven | Brooks | 2020 | $195,679 |
Learning in a Time of Crisis_ Creating a Canadian Emergency Department COVID19 Registry | Corinne | Hohl | 2020 | $250,000.00 $2,943,536.00 $75,000.00 $2,500,000.00 $250,000.00 $1,216,180.00 |
Mitigating the collateral effects of COVID-19 community control in Canada: promoting mental health outcomes and well-being among front line healthcare providers and first responders | Kerstin | DeWit | 2020 | |
Implementation of the Canadian Clinical Practice Guideline for the diagnosis of Acute aortic syndrome | Robert | Ohle | 2020 | |
High-Dose versus Standard Dose Cephalexin for Non-Purulent Cellulitis | Krishan | Yadav | 2020 | $98,400.00 $10,000.00 $10,000.00 $382,500 |
PEITHO-3. Reduced-dose thrombolytic treatment for patients with higher-intermediate risk acute pulmonary embolism | Kerstin | de Wit | 2020 | $625,000 $478,125 |
A best practice diagnostic and treatment algorithm for benign paroxysmal positional vertigo: A multi centre implementation study | Robert | Ohle | 2020 | |
Understanding Delirium Pathophysiology using Urine Metabolomics from Older People with Hip Fractures | Jacques | Lee | 2020 | $221,000.00 |
Canadian Head CT Patient Decision Aid Consensus Study | Patrick | Archambault | 2020 | $25,000.00 $190,392.05 |
Evaluating the Assessments: a multi-centre program evaluation of emergency medicine entrustable professional assessment data from 2018-2023 | Teresa | Chan | 2020 | |
Quantity of Opioids for Acute Pain and Limit Unused Medication | Raoul | Daoust | 2020 | $742,051 |
Multi-Center Cluster-Randomized Implementation of Canadian Syncope Risk Score based Practice Recommendations for Emergency Department Syncope Management | Venkatesh | Thiruganasambandamoorthy | 2020 | $397,800 $100,000 $748,154 $336,618 |
Venous thromboembolism in patients discharged from the emergency department with ankle fractures: A population-based cohort study | Keerat | Grewal | 2020 | $50,000 $2,000 |
Development and Evaluation of a National Simulation-Based Examination in Emergency Medicine | Andrew K. | Hall | 2020 | |
Enabling Knowledge Translation in the Age of Social Media: Developing a Social Media KT Toolkit | Teresa | Chan | 2020 | $300,000 |
Evaluating The Use of ActionADE to Flag Patients with Suspected Prescription Opioid Misuse: A Randomized Control Trial | Corinne | Hohl | 2021 | |
Health Research Training Platform(2021/22 Pilot): Canadian Collaborative Training Platform in Resuscitation Sciences(CCTPRS) | Katie | Dainty | 2021 | |
Canadian TIA - Prospective Cohort Study-Phase III | Jeff | Perry | 2021 | |
Using Data from the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) to Describe the Patients’ Experiences with the Long Hauler Syndrome | Patrick | Archambault | 2021 | $499,945 |
Implementing and Evaluating ActionADE to Transform Medication Safety | Corinne | Hohl | 2022 | |
Using Data from Canadian Emergency Department Patients to Estimate Vaccine Effectiveness Against COVID-19 Virus Variants of Concern | Steven | Brooks | 2022 | $496,134 |
Evaluation of a diabetes navigator on post-discharge outcomes for patients with diabetes after an emergency department visit for hyperglycemia: a pilot randomized controlled trial | Justin | Yan | 2022 | |
Impact of Vitamin C on the Reduction of Opioid Consumption After an Emergency Department Visit for Acute Musculoskeletal Pain: A Double-Blind Randomized Control Trial Protocol | Raoul | Daoust | 2022 | |
Canadian Emergency Department Rapid Response Network and ActionADE Core Network Partner for Canadian Agency for Drugs and Technologies in Health | Corinne | Hohl | 2022 | |
Canadian COVID-19 Emergency Department Rapid Response Network: Supporting Clinical and Policy Decisions in an Evolving Pandemic | Corinne | Hohl | 2022 | |
Using an Experience Based Co-Design Process to Build a Supportive Care Model for Adult Survivors of Sudden Cardiac Arrest | Katie | Dainty | 2022 | |
Caring for Each other in Emergency Departments: An Indigenous Led Anti-Racism Implementation Project – Alignment and Partnership Building | Patrick | McLane | 2022 | $190,500 |
Validation of the Falls Clinical Decision Rule for diagnosing intracranial bleeding in older emergency department patients | Kerstin | de Wit | 2023 | $857,756 |
Canadian emergency department-designed pulmonary embolism testing (the CEDD-PET study) | Kerstin | de Wit | 2023 | 1,396,125 |
Derivation and validation of a prehospital risk stratification tool to predict the need for ambulance transport to an emergency department after a fall in older adults. | Eric | Mercier | 2023 | |
Development, implementation and evaluation of a patient-oriented quality improvement program targeting care transitions of elderly with major neurocognitive disorders and their caregivers. | Patrick | Archambault | 2023 | $952,500 |
Validation of a clinical risk score to predict a serious cause of vertigo in patients presenting to the emergency department. | Robert | Ohle | 2023 | |
Redéfinir la neuro-imagerie pour les patients âgés souffrant de traumatisme cranio-cérébral léger | Marcel | Emond | 2023 | |
Validation et raffinement de l’outil QueBIC pour les patients avec un traumatisme craniocérébral léger complexe | Marcel | Emond | 2023 | $478,126 |
Physiotherapy care in Emergency Departments for Patients with Musculoskeletal Disorders: A Pragmatic Cluster Randomized Controlled Trial and Cost Analysis | Marcel | Emond | 2023 | $608,175 |
Optimisation des soins intégrés multidisciplinaires pour les fractures de la hanche chez l’aîné | Marcel | Emond | 2023 | |
Psychopathology following OHCA | Steven | Brooks | 2023 | |
Advancing Anti-Racist and Equity-Oriented Care in the Emergency Department with First Nations Partners | Patrick | McLane | 2023 | $572,500 $1,751,852 |
Expanding the Patient-Oriented Research Capacity of the Canadian Emergency Department Rapid Response Network.pdf | Patrick | Archambault | 2023 | |
Development of a Best Practice Checklist for Emergency Department Management of Skin and Soft Tissue Infections | Krishan | Yadav | 2023 | |
Optimizing outcomes for patients presenting to emergency departments with opioid use disorder | Corinne | Hohl | 2024 | |
Does Vitamin C provide an Analgesic effect on Acute MSK Injury After an Emergency Department Visit: A Randomized Control Trial | Raoul | Daoust | 2024 | |
Sentinel Surveillance Methods for Serious Adverse Drug Events to Outpatient Medications | Corinne | Hohl | 2024 | |